Eintrag weiter verarbeiten
Verfügbar über Online-Ressource

IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel: Neuro-Oncology
Personen und Körperschaften: Henderson, Jacob, Wood, Matt, Weinberg, Andrew, Cho, Yoon-Jae
In: Neuro-Oncology, 21, 2019, Supplement_2, S. ii98-ii98
Format: E-Article
Sprache: Englisch
veröffentlicht:
Oxford University Press (OUP)
Schlagwörter:
Cancer Research
Neurology (clinical)
Oncology
author_facet Henderson, Jacob
Wood, Matt
Weinberg, Andrew
Cho, Yoon-Jae
Henderson, Jacob
Wood, Matt
Weinberg, Andrew
Cho, Yoon-Jae
author Henderson, Jacob
Wood, Matt
Weinberg, Andrew
Cho, Yoon-Jae
spellingShingle Henderson, Jacob
Wood, Matt
Weinberg, Andrew
Cho, Yoon-Jae
Neuro-Oncology
IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
Cancer Research
Neurology (clinical)
Oncology
author_sort henderson, jacob
spelling Henderson, Jacob Wood, Matt Weinberg, Andrew Cho, Yoon-Jae 1522-8517 1523-5866 Oxford University Press (OUP) Cancer Research Neurology (clinical) Oncology http://dx.doi.org/10.1093/neuonc/noz036.143 IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA Neuro-Oncology
doi_str_mv 10.1093/neuonc/noz036.143
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9uZXVvbmMvbm96MDM2LjE0Mw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9uZXVvbmMvbm96MDM2LjE0Mw
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Oxford University Press (OUP), 2019
imprint_str_mv Oxford University Press (OUP), 2019
issn 1522-8517
1523-5866
issn_str_mv 1522-8517
1523-5866
language English
mega_collection Oxford University Press (OUP) (CrossRef)
match_str henderson2019immu24ox40agonismasapotenttreatmentforimmuneprimedhighriskmedulloblastoma
publishDateSort 2019
publisher Oxford University Press (OUP)
recordtype ai
record_format ai
series Neuro-Oncology
source_id 49
title IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_unstemmed IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_full IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_fullStr IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_full_unstemmed IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_short IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_sort immu-24. ox40 agonism as a potent treatment for immune-primed high risk medulloblastoma
topic Cancer Research
Neurology (clinical)
Oncology
url http://dx.doi.org/10.1093/neuonc/noz036.143
publishDate 2019
physical ii98-ii98
description
container_issue Supplement_2
container_start_page 0
container_title Neuro-Oncology
container_volume 21
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792326607573090313
geogr_code not assigned
last_indexed 2024-03-01T12:24:11.768Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=IMMU-24.+OX40+AGONISM+AS+A+POTENT+TREATMENT+FOR+IMMUNE-PRIMED+HIGH+RISK+MEDULLOBLASTOMA&rft.date=2019-04-23&genre=article&issn=1523-5866&volume=21&issue=Supplement_2&pages=ii98-ii98&jtitle=Neuro-Oncology&atitle=IMMU-24.+OX40+AGONISM+AS+A+POTENT+TREATMENT+FOR+IMMUNE-PRIMED+HIGH+RISK+MEDULLOBLASTOMA&aulast=Cho&aufirst=Yoon-Jae&rft_id=info%3Adoi%2F10.1093%2Fneuonc%2Fnoz036.143&rft.language%5B0%5D=eng
SOLR
_version_ 1792326607573090313
author Henderson, Jacob, Wood, Matt, Weinberg, Andrew, Cho, Yoon-Jae
author_facet Henderson, Jacob, Wood, Matt, Weinberg, Andrew, Cho, Yoon-Jae, Henderson, Jacob, Wood, Matt, Weinberg, Andrew, Cho, Yoon-Jae
author_sort henderson, jacob
container_issue Supplement_2
container_start_page 0
container_title Neuro-Oncology
container_volume 21
description
doi_str_mv 10.1093/neuonc/noz036.143
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9uZXVvbmMvbm96MDM2LjE0Mw
imprint Oxford University Press (OUP), 2019
imprint_str_mv Oxford University Press (OUP), 2019
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1522-8517, 1523-5866
issn_str_mv 1522-8517, 1523-5866
language English
last_indexed 2024-03-01T12:24:11.768Z
match_str henderson2019immu24ox40agonismasapotenttreatmentforimmuneprimedhighriskmedulloblastoma
mega_collection Oxford University Press (OUP) (CrossRef)
physical ii98-ii98
publishDate 2019
publishDateSort 2019
publisher Oxford University Press (OUP)
record_format ai
recordtype ai
series Neuro-Oncology
source_id 49
spelling Henderson, Jacob Wood, Matt Weinberg, Andrew Cho, Yoon-Jae 1522-8517 1523-5866 Oxford University Press (OUP) Cancer Research Neurology (clinical) Oncology http://dx.doi.org/10.1093/neuonc/noz036.143 IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA Neuro-Oncology
spellingShingle Henderson, Jacob, Wood, Matt, Weinberg, Andrew, Cho, Yoon-Jae, Neuro-Oncology, IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA, Cancer Research, Neurology (clinical), Oncology
title IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_full IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_fullStr IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_full_unstemmed IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_short IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
title_sort immu-24. ox40 agonism as a potent treatment for immune-primed high risk medulloblastoma
title_unstemmed IMMU-24. OX40 AGONISM AS A POTENT TREATMENT FOR IMMUNE-PRIMED HIGH RISK MEDULLOBLASTOMA
topic Cancer Research, Neurology (clinical), Oncology
url http://dx.doi.org/10.1093/neuonc/noz036.143